Screening for M-proteinemia consisting of monoclonal gammopathy of undetermined significance and multiple myeloma for 30 years among atomic bomb survivors in Hiroshima.

Fujimura, Kingo; Sugiyama, Aya; Akita, Tomoyuki; Ohisa, Masayuki; Nagashima, Shintaro; Katayama, Keiko; Maeda, Ryo; Tanaka, Junko

Screening for M-proteinemia consisting of monoclonal gammopathy of undetermined significance and multiple myeloma for 30 years among atomic bomb survivors in Hiroshima.

Fujimura, Kingo; Sugiyama, Aya; Akita, Tomoyuki; Ohisa, Masayuki; Nagashima, Shintaro; Katayama, Keiko; Maeda, Ryo; Tanaka, Junko.

Afiliação

Fujimura K; Department of Nursing, Yasuda Women's University, 6-13-1 Yasuhigashi Asaminami ward, Hiroshima City, 731-0153, Japan. k-fujimu@yasuda-u.ac.jp.
Sugiyama A; Hiroshima Atomic Bomb Causality Council, Hiroshima City, Japan. k-fujimu@yasuda-u.ac.jp.
Akita T; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima City, Japan.
Ohisa M; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima City, Japan.
Nagashima S; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima City, Japan.
Katayama K; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima City, Japan.
Maeda R; Department of Nursing, Yasuda Women's University, 6-13-1 Yasuhigashi Asaminami ward, Hiroshima City, 731-0153, Japan.
Tanaka J; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima City, Japan.

Int J Hematol ; 113(4): 576-585, 2021 Apr.

Article em En | MEDLINE | ID: mdl-33389658

Assuntos

Sobreviventes de Bombas Atômicas; Gamopatia Monoclonal de Significância Indeterminada/sangue; Gamopatia Monoclonal de Significância Indeterminada/epidemiologia; Mieloma Múltiplo/sangue; Mieloma Múltiplo/epidemiologia; Proteínas do Mieloma; Adolescente; Adulto; Idoso; Sobreviventes de Bombas Atômicas/estatística & dados numéricos; Biomarcadores Tumorais; Criança; Feminino; Seguimentos; Humanos; Imunoglobulina A/sangue; Imunoglobulina G/sangue; Imunoglobulina M; Incidência; Japão/epidemiologia; Estimativa de Kaplan-Meier; Masculino; Programas de Rastreamento; Pessoa de Meia-Idade; Gamopatia Monoclonal de Significância Indeterminada/diagnóstico; Gamopatia Monoclonal de Significância Indeterminada/etiologia; Mieloma Múltiplo/diagnóstico; Mieloma Múltiplo/etiologia; Prevalência; Modelos de Riscos Proporcionais; Fatores de Risco; Adulto Jovem

Palavras-chave

A-bomb survivors; Incidence; MGUS; Prevalence; Radiation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Gamopatia Monoclonal de Significância Indeterminada / Proteínas do Mieloma / Sobreviventes de Bombas Atômicas / Mieloma Múltiplo Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google